Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_18-cv-00355/USCOURTS-cand-3_18-cv-00355-4/pdf.json

Nature of Suit Code: 890
Nature of Suit: Other Statutory Actions
Cause of Action: 15:1125 Trademark Infringement (Lanham Act)

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

PETER M. BRODY (pro hac vice) 

MARK S. POPOFSKY(CSB # 175476) 

ROPES & GRAY LLP

2099 Pennsylvania Avenue, NW 

Washington, DC 20006-6807 

Tel: 202-508-4600 

Fax: 202-508-4650 

peter.brody@ropesgray.com 

DAVID S. CHUN (CSB # 315958) 

ROPES & GRAY LLP

1900 University Avenue 

East Palo Alto, CA 94303-2284 

Tel: 650-617-4000 

Fax: 650-617-4090 

david.chun@ropesgray.com 

ANNE JOHNSON PALMER 

(CSB # 302235) 

ROPES & GRAY LLP

Three Embarcadero Center

San Francisco, CA 94111-4006 

Tel: 415-315-6300 

Fax: 415-315-6350 

anne.johnsonpalmer@ropesgray.com 

Attorneys for Plaintiff, 

BAUSCH HEALTH US, LLC

SHASHANK UPADHYE (pro hac vice)

YIXIN TANG (pro hac vice)

BRENT BATZER (pro hac vice)

UPADHYE CWIK LLP

135 S LaSalle St. Suite 1930 

Chicago, IL 60603 

Tel: 312.598.2610 

shashank@ipfdalaw.com 

yixin@ipfdalaw.com 

brent@ipfdalaw.com 

BENJAMIN L. ENGLAND (pro hac vice) 

JESSICA R. RIFKIN (pro hac vice) 

BENJAMIN L. ENGLAND & 

ASSOCIATES, LLC

810 Landmark Drive, Suite 126 

Glen Burnie, MD 21061 

Tel: (410) 220-2800 

Fax: (443) 583-1464 

blengland@fdaimports.com 

jrrifkin@fdaimports.com 

Attorneys for Defendant, 

ECI PHARMACEUTICALS LLC

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN FRANCISCO DIVISION

BAUSCH HEALTH US, LLC,

Plaintiff,

v. 

ECI PHARMACEUTICALS LLC,

Defendant.

Case No. 18-CV-00355-RS

STIPULATION AND ORDER 

CONCERNING MODIFICATION OF

SCHEDULING ORDER $602',),('

%<7+(&2857

Case 3:18-cv-00355-RS Document 166 Filed 02/26/20 Page 1 of 7
2

STIPULATION AND [PROPOSED] ORDER

CASE NO. 18-CV-00355-RS

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Pursuant to Civil Local Rule 6-2, 7-1(a)(5), and 7-12, Plaintiff Bausch Health US, LLC 

(“Bausch”) and Defendant ECI Pharmaceuticals LLC (“ECI”) (jointly, the “Parties”), by and 

through their respective counsel, hereby stipulate as follows: 

WHEREAS the following time modifications have been previously made in this case:

A thirty (30) day extension of time, until January 19, 2018, for Defendant to file a Rule 12 

motion, answer, or otherwise respond to the complaint in Plaintiff’s originally-filed action against 

Defendant and other parties (Dkt. 21; Chun Declaration in Support of Stipulation and Proposed 

Order (“Chun Decl.”), ¶ 5); 

A further extension of Defendant’s deadline to file a responsive pleading until twenty-one 

(21) days after Plaintiff filed its amended complaint in this severed action, which was so Ordered

by the Court on January 16, 2018 (Dkt. 34; Chun Decl. ¶ 6);

Further extensions of time for Plaintiff to file its Opposition to Defendant’s Rule 12 

Motion filing and Defendant to file its Reply to March 27, 2018 and April 24, 2018, respectively 

(Dkt. 40; Chun Decl. ¶ 9);

A stay of the case from May 4, 2018 to July 31, 2018 pursuant to 28 U.S.C. § 1659(a) 

pending the determination or termination of ITC Investigation No. 337-TA-1109, captioned “In 

the Matter of Certain Clidinium Bromide and Products Containing Same” (Dkts. 70, 72; Chun 

Decl. ¶ 10);

A modification of the schedule setting the deadline for the Defendant to file its Reply in 

Support of its Motion to Dismiss for October 12, 2018 and setting a Joint Hearing on the Motion 

to Dismiss for October 25, 2018 (Dkt. 79; Chun Decl. ¶ 11);

An extension of the time for Plaintiff to respond to Defendant’s amended answer and for 

Defendant to file opposition papers (Dkt. 108; Chun Decl. ¶ 17);

A modification of the schedule extending all discovery deadlines and the trial date (Dkt. 

122; Chun Decl. ¶ 22);

A modification of the schedule setting the deadline for Plaintiff to answer Defendant’s 

counterclaims and further modify the scheduling order (Dkt. 102) with respect to fact and expert 

discovery deadlines (Dkt. 136; Chun Decl. ¶ 23);

Case 3:18-cv-00355-RS Document 166 Filed 02/26/20 Page 2 of 7
3

STIPULATION AND [PROPOSED] ORDER

CASE NO. 18-CV-00355-RS

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

A modification of the schedule setting the deadline for amended pleadings at February 7, 

2020 (Dkt. 150; Chun Decl. ¶ 27);

A modification of the schedule extending discovery deadlines (Dkt. 155; Chun Decl. ¶

28);

WHEREAS the Parties submitted to this Court under seal on January 9, 2020 a Joint 

Letter Brief Regarding Certain Discovery Disputes (the “Initial Joint Letter”) (Dkt. 144; Chun 

Decl. ¶ 25); 

WHEREAS the discovery disputes raised in the Parties’ Initial Joint Letter were referred 

to Magistrate Judge Kandis A. Westmore on January 15, 2020 (Dkts. 147, 153, 158-60; Chun 

Decl. ¶¶ 26, 29); 

WHEREAS ECI filed a Second Amended Answer and Counterclaims on February 7, 2020 

(Dkt. 157; Chun Decl. ¶ 30), in which ECI expanded certain of the allegations advanced in its 

counterclaims; 

WHEREAS, after further attempts to meet and confer, as required by Magistrate Judge 

Westmore’s order of January 21, 2020, the Parties filed three Joint Letters regarding certain 

discovery disputes on February 14, 2020 (the “Joint Letters”) (Dkts. 158-160; Chun Decl. ¶ 31);

WHEREAS Bausch filed an Answer to ECI’s Second Amended Counterclaims on 

February 21, 2020 (Dkt. 162; Chun Decl. ¶ 32);

WHEREAS the Parties are engaged in active settlement discussions (Chun Decl. ¶ 33); 

WHEREAS the Joint Letters remain pending, such that the Parties await Magistrate Judge 

Westmore’s ruling on their outstanding discovery disputes (Chun Decl. ¶ 31);

WHEREAS the Parties believe that good cause exists for modification of the scheduling 

order and an extension of the jury trial commencement date to a date on or after December 1, 

2020 at the Court’s convenience, to allow the Parties sufficient time to conclude discovery after 

the resolution of the discovery disputes, and to file dispositive motions and prepare for trial 

(Chun Decl. ¶¶ 34-35);

WHEREAS the Parties also believe that good cause exists for modification of the 

scheduling order and an extension of the jury trial commencement date to a date on or after 

Case 3:18-cv-00355-RS Document 166 Filed 02/26/20 Page 3 of 7
4

STIPULATION AND [PROPOSED] ORDER

CASE NO. 18-CV-00355-RS

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Event Current Date Date

Close of all non-expert 

discovery

 February 28, 2020 225 days before trial

Designation of experts in 

accordance with FRCP 26(a)(2)

 March 13, 2020 200 days before trial

Designation of supplemental 

and rebuttal experts in 

accordance with FRCP 26(a)(2)

 April 17, 2020 170 days before trial

Completion of all discovery of 

expert witnesses pursuant FRCP 

26(b)(4)

May 8, 2020 145 days before trial

Deadline for hearing of all 

pretrial motions

July 2, 2020 100 days before trial

Pretrial Conference On or about September 2, 2020 

at 10:00am

25 days before trial 

Jury Trial Commences Beginning on or after 

September 28, 2020 at 9:00 am 

December , 2020 

(Chun Decl. ¶ 37); and

WHEREAS the Parties do not believe that the proposed time modifications would cause 

prejudice to any party (Chun Decl. ¶ 38); 

NOW THERFORE, in order to effectuate the Parties’ intent as set forth herein, the Parties, 

by and through their respective counsel, stipulate to and respectfully request that the Court enter 

an Order to extend the deadlines and trial date as shown above. 

December 1, 2020 at the Court’s convenience, to allow the parties time to continue their 

productive settlement discussions (Chun Decl. ¶ 36);

WHEREAS the Parties agree, subject to this Court’s approval, to modify the current

scheduling order (Dkt. 102, as modified by Dkts. 136 and 155, respectively) as follows: 

[[[[[[[[[[[[[[[[

$XJXVW

[[[[[[[[[[[[[[[[

1RYHPEHUDWDP

DWDP

Case 3:18-cv-00355-RS Document 166 Filed 02/26/20 Page 4 of 7
5

STIPULATION AND [PROPOSED] ORDER

CASE NO. 18-CV-00355-RS

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Dated: February 26, 2020 /s/ David S. Chun 

DAVID S. CHUN (CSB # 315958) 

ROPES & GRAY LLP

1900 University Avenue 

East Palo Alto, CA 94303-2284 

Tel: 650-617-4000 

Fax: 650-617-4090 

david.chun@ropesgray.com 

PETER M. BRODY (pro hac vice) 

MARK S. POPOFSKY(CSB # 175476)

ROPES & GRAY LLP

2099 Pennsylvania Avenue, NW 

Washington, DC 20006-6807 

Tel: 202-508-4600 

Fax: 202-508-4650 

peter.brody@ropesgray.com 

ANNE JOHNSON PALMER (CSB # 302235) 

ROPES & GRAY LLP

Three Embarcadero Center

San Francisco, CA 94111-4006 

Tel: 415-315-6300 

Fax: 415-315-6350 

anne.johnsonpalmer@ropesgray.com 

Attorneys for Plaintiff, 

BAUSCH HEALTH US, LLC

Dated: February 26, 2020 /s/ Yixin Tang 

Shashank Upadhye (pro hac vice) 

Yixin Tang (pro hac vice) 

Brent Batzer (pro hac vice) 

UPADHYE CWIK LLP

135 S LaSalle St., Suite 1930 

Chicago, IL 60603 

Tel: 312.598.2610 

shashank@ipfdalaw.com 

yixin@ipfdalaw.com 

brent@ipfdalaw.com 

Benjamin L. England (pro hac vice) 

Jessica R. Rifkin (pro hac vice) 

BENJAMIN L. ENGLAND & ASSOCIATES, 

LLC

810 Landmark Drive, Suite 126 

Glen Burnie, MD 21061 

Case 3:18-cv-00355-RS Document 166 Filed 02/26/20 Page 5 of 7
6

STIPULATION AND [PROPOSED] ORDER

CASE NO. 18-CV-00355-RS

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Tel: (410) 220-2800 

Fax: (443) 583-1464 

blengland@fdaimports.com

jrrifkin@fdaimports.com

Counsel for Defendant

ECI Pharmaceuticals, LLC

Case 3:18-cv-00355-RS Document 166 Filed 02/26/20 Page 6 of 7
7

STIPULATION AND [PROPOSED] ORDER

CASE NO. 18-CV-00355-RS

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

ORDER

PURSUANT TO STIPULATION, IT IS SO ORDERED.

Dated: ______________, 2020. ___________________________________

Honorable Richard Seeborg 

United States District Judge

)HEUXDU\

Case 3:18-cv-00355-RS Document 166 Filed 02/26/20 Page 7 of 7